CA2810078A1 - Needle-free injectors and design parameters thereof that optimize injection performance - Google Patents
Needle-free injectors and design parameters thereof that optimize injection performance Download PDFInfo
- Publication number
- CA2810078A1 CA2810078A1 CA2810078A CA2810078A CA2810078A1 CA 2810078 A1 CA2810078 A1 CA 2810078A1 CA 2810078 A CA2810078 A CA 2810078A CA 2810078 A CA2810078 A CA 2810078A CA 2810078 A1 CA2810078 A1 CA 2810078A1
- Authority
- CA
- Canada
- Prior art keywords
- injector
- pressure
- needle
- delivery
- needle free
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000007924 injection Substances 0.000 title claims abstract description 99
- 238000002347 injection Methods 0.000 title claims abstract description 99
- 238000013461 design Methods 0.000 title description 11
- 239000000203 mixture Substances 0.000 claims abstract description 78
- 238000009472 formulation Methods 0.000 claims abstract description 74
- 239000012669 liquid formulation Substances 0.000 claims abstract description 7
- 230000003247 decreasing effect Effects 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 41
- 239000007788 liquid Substances 0.000 description 41
- 239000003814 drug Substances 0.000 description 39
- 229940079593 drug Drugs 0.000 description 27
- 210000003491 skin Anatomy 0.000 description 23
- 238000001727 in vivo Methods 0.000 description 21
- 239000000463 material Substances 0.000 description 17
- 238000012360 testing method Methods 0.000 description 15
- 238000000338 in vitro Methods 0.000 description 13
- 239000003708 ampul Substances 0.000 description 10
- 210000002615 epidermis Anatomy 0.000 description 9
- 230000007246 mechanism Effects 0.000 description 8
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 8
- 239000004810 polytetrafluoroethylene Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000008186 active pharmaceutical agent Substances 0.000 description 7
- 239000000306 component Substances 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 230000035515 penetration Effects 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 230000000007 visual effect Effects 0.000 description 7
- 230000008901 benefit Effects 0.000 description 6
- 238000010254 subcutaneous injection Methods 0.000 description 6
- 239000007929 subcutaneous injection Substances 0.000 description 6
- 210000004304 subcutaneous tissue Anatomy 0.000 description 6
- 208000012266 Needlestick injury Diseases 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 238000012377 drug delivery Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 206010033675 panniculitis Diseases 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 4
- 229940090047 auto-injector Drugs 0.000 description 4
- 239000000969 carrier Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000012864 cross contamination Methods 0.000 description 4
- 239000013583 drug formulation Substances 0.000 description 4
- 230000003628 erosive effect Effects 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- -1 opioids Substances 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 206010034912 Phobia Diseases 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000004146 energy storage Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 238000007918 intramuscular administration Methods 0.000 description 3
- 239000007927 intramuscular injection Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 208000019899 phobic disease Diseases 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 208000019695 Migraine disease Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 229940125385 biologic drug Drugs 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 229940088679 drug related substance Drugs 0.000 description 2
- 230000002163 immunogen Effects 0.000 description 2
- 208000000509 infertility Diseases 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 208000021267 infertility disease Diseases 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000036470 plasma concentration Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000006561 Cluster Headache Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010073753 Fear of injection Diseases 0.000 description 1
- 208000007984 Female Infertility Diseases 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 102400000321 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- GUTXTARXLVFHDK-UHFFFAOYSA-N Haloperidol decanoate Chemical compound C1CC(OC(=O)CCCCCCCCC)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 GUTXTARXLVFHDK-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 206010021928 Infertility female Diseases 0.000 description 1
- 102000006992 Interferon-alpha Human genes 0.000 description 1
- 108010047761 Interferon-alpha Proteins 0.000 description 1
- 206010027603 Migraine headaches Diseases 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940034982 antineoplastic agent Drugs 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 229940125687 antiparasitic agent Drugs 0.000 description 1
- 239000000164 antipsychotic agent Substances 0.000 description 1
- 229940005529 antipsychotics Drugs 0.000 description 1
- 239000003699 antiulcer agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 239000005388 borosilicate glass Substances 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 239000000168 bronchodilator agent Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 239000002327 cardiovascular agent Substances 0.000 description 1
- 229940125692 cardiovascular agent Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003576 central nervous system agent Substances 0.000 description 1
- 229940125693 central nervous system agent Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000018912 cluster headache syndrome Diseases 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical class CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000011982 device technology Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 239000004811 fluoropolymer Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 229960005007 haloperidol decanoate Drugs 0.000 description 1
- 230000010224 hepatic metabolism Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000012623 in vivo measurement Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229940090046 jet injector Drugs 0.000 description 1
- 239000012633 leachable Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000013178 mathematical model Methods 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 238000010197 meta-analysis Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000006070 nanosuspension Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229940005483 opioid analgesics Drugs 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 230000002138 osteoinductive effect Effects 0.000 description 1
- 230000008058 pain sensation Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229940124811 psychiatric drug Drugs 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 229960000160 recombinant therapeutic protein Drugs 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- IMCGHZIGRANKHV-AJNGGQMLSA-N tert-butyl (3s,5s)-2-oxo-5-[(2s,4s)-5-oxo-4-propan-2-yloxolan-2-yl]-3-propan-2-ylpyrrolidine-1-carboxylate Chemical compound O1C(=O)[C@H](C(C)C)C[C@H]1[C@H]1N(C(=O)OC(C)(C)C)C(=O)[C@H](C(C)C)C1 IMCGHZIGRANKHV-AJNGGQMLSA-N 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
- A61M5/3007—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules with specially designed jet passages at the injector's distal end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38320510P | 2010-09-15 | 2010-09-15 | |
| US61/383,205 | 2010-09-15 | ||
| PCT/US2011/051617 WO2012037268A2 (en) | 2010-09-15 | 2011-09-14 | Needle-free injectors and design parameters thereof that optimize injection performance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2810078A1 true CA2810078A1 (en) | 2012-03-22 |
Family
ID=45807406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2810078A Abandoned CA2810078A1 (en) | 2010-09-15 | 2011-09-14 | Needle-free injectors and design parameters thereof that optimize injection performance |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US8734384B2 (https=) |
| EP (1) | EP2616123A4 (https=) |
| JP (2) | JP5856621B2 (https=) |
| CN (2) | CN104958813A (https=) |
| AU (1) | AU2011302072B2 (https=) |
| CA (1) | CA2810078A1 (https=) |
| WO (1) | WO2012037268A2 (https=) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9108026B2 (en) * | 2009-07-09 | 2015-08-18 | Cook Medical Technologies Llc | Spring action medical device |
| US8734384B2 (en) * | 2010-09-15 | 2014-05-27 | Zogenix, Inc. | Needle-free injectors and design parameters thereof that optimize injection performance |
| EP2732770B1 (de) * | 2012-11-16 | 2016-08-24 | Erbe Elektromedizin GmbH | Nadellose Injektionsvorrichtung |
| WO2014093818A2 (en) * | 2012-12-14 | 2014-06-19 | Bioject, Inc. | Use of a novel subcutaneous needle-free technique to deliver testosterone in hypogonadal men |
| CN103323174B (zh) * | 2013-06-09 | 2015-02-11 | 东南大学 | 一种无针注射射流压力的测量装置的测量方法 |
| KR102320331B1 (ko) * | 2013-08-27 | 2021-11-03 | 레프로-메드 시스템즈, 인코포레이티드 | 피하 치료를 위한 바늘을 선택하는 방법 |
| CN105448172A (zh) * | 2015-12-30 | 2016-03-30 | 天津天堰科技股份有限公司 | 教学用模拟注射器 |
| CN105413024A (zh) * | 2016-01-07 | 2016-03-23 | 深圳市赫拉铂氢时代科技有限公司 | 纳米/微米氢水无针注射仪及其注射方法 |
| US9724473B2 (en) * | 2016-01-12 | 2017-08-08 | Nickolas Peter Demas | Multi-directional low-displacement force sensor |
| ES2814287T3 (es) * | 2016-03-15 | 2021-03-26 | Amgen Inc | Reducir la probabilidad de rotura de cristal en dispositivos de administración de fármaco |
| US10251964B2 (en) | 2016-08-23 | 2019-04-09 | Drma Group International Llc | Self-disinfecting needleless device |
| US10195110B2 (en) | 2016-09-08 | 2019-02-05 | Drma Group International Llc | Capping device for disinfecting medical container |
| US10391294B2 (en) | 2016-09-12 | 2019-08-27 | Drma Group International Llc | Disinfecting cap |
| US10610676B2 (en) | 2016-09-26 | 2020-04-07 | Drma Group International Llc | Disinfecting luer connector |
| US10182968B2 (en) | 2017-03-06 | 2019-01-22 | Drma Group International Llc | Disinfecting capping device for sharp medical objects |
| JP7329307B2 (ja) * | 2017-06-27 | 2023-08-18 | 株式会社ダイセル | 無針注射器の製造方法、無針注射器における点火薬及びガス発生剤の量を設定する方法、および無針注射器の射出パラメータ算出プログラム |
| US11541219B2 (en) | 2017-07-10 | 2023-01-03 | Drma Group International Llc | Capping device for disinfecting medical injection membranes |
| FR3078489B1 (fr) | 2018-03-01 | 2025-06-27 | Oreal | Cartouche pour dispositif d'injection sans aiguille |
| FR3082712B1 (fr) | 2018-06-26 | 2020-07-31 | Oreal | Systeme d'injection sans aiguille |
| CN112534274B (zh) * | 2018-07-25 | 2023-10-13 | 株式会社大赛璐 | 测定系统、测定方法、注入器、以及使用该注入器向注入对象的细胞内注入包含生物分子的溶液的注入方法 |
| CN112336949A (zh) * | 2019-08-08 | 2021-02-09 | 武汉大学 | 一种气动式无针注射驱动气压切换装置及其使用方法 |
| CN110292684B (zh) * | 2019-08-09 | 2024-07-05 | 江苏丞宇米特医疗科技有限公司 | 一次装药多次注射双压力无针注射器 |
| WO2021089163A1 (en) | 2019-11-07 | 2021-05-14 | L'oreal | Needleless injection device for in-situ reaction |
| JP2021095353A (ja) | 2019-12-16 | 2021-06-24 | ロレアル | ヒアルロン酸の液滴を使用する美容方法 |
| US11752269B2 (en) | 2019-12-18 | 2023-09-12 | Integrimedical Llc | Spring loaded medical needle-free injection system |
| FR3115692B1 (fr) | 2020-10-30 | 2024-03-01 | Oreal | Gouttelettes comprenant un composé non polymérique |
| CN112908468B (zh) * | 2021-01-23 | 2024-01-12 | 上海熙软科技有限公司 | 一种基于5g网络的智慧医疗管理系统 |
| CN113318301A (zh) * | 2021-06-28 | 2021-08-31 | 北京科技大学 | 一种大剂量多孔无针注射器 |
| CN115068747A (zh) * | 2022-07-21 | 2022-09-20 | 汤小彬 | 一种气压式无针注射手柄 |
| CN117861021B (zh) * | 2024-02-27 | 2024-10-15 | 江苏乐聚医药科技有限公司 | 一次性药芯单次装药多次注射的无针注射器及其配置方法 |
| WO2025206737A1 (ko) * | 2024-03-26 | 2025-10-02 | 바즈바이오메딕 주식회사 | 무바늘 주사기 |
| WO2025206734A1 (ko) * | 2024-03-26 | 2025-10-02 | 바즈바이오메딕 주식회사 | 무바늘 주사기 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3859996A (en) | 1973-07-18 | 1975-01-14 | Mizzy Inc | Multi-dose injector |
| US4421508A (en) | 1981-02-24 | 1983-12-20 | Cohen Edgar C | Vacuum-compression injector |
| DE3115376A1 (de) | 1981-04-16 | 1982-12-16 | Hoechst Ag, 6000 Frankfurt | Nadelloses injektionsgeraet |
| DE3115375A1 (de) | 1981-04-16 | 1982-11-11 | Hoechst Ag, 6000 Frankfurt | Kolbenpumpe fuer nadellose injektionsgeraete |
| HU186718B (en) | 1983-06-29 | 1985-09-30 | Radelkis Electrokemiai | Automatic needleless syringe operable by cardox cylinder suitable for personal giving injection e.g. insulin |
| US4913699A (en) | 1988-03-14 | 1990-04-03 | Parsons James S | Disposable needleless injection system |
| EP0347190A1 (en) | 1988-06-14 | 1989-12-20 | Vci Corporation | Needleless vacuum-compression injector |
| AU6550990A (en) | 1989-11-09 | 1991-05-16 | Bioject, Inc. | Needleless hypodermic injection device |
| WO1992008508A1 (en) | 1990-11-09 | 1992-05-29 | Sy-Quest International Limited | Needleless hypodermic jet injector device |
| GB9118204D0 (en) | 1991-08-23 | 1991-10-09 | Weston Terence E | Needle-less injector |
| US5383851A (en) * | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| CA2167586C (en) | 1993-07-31 | 2005-01-25 | Terence Edward Weston | Needle-less injector |
| GB9425642D0 (en) | 1994-12-20 | 1995-02-22 | Weston Medical Ltd | Filling device |
| GB9504878D0 (en) | 1995-03-10 | 1995-04-26 | Weston Medical Ltd | Viscously coupled actuator |
| GB9525757D0 (en) | 1995-12-16 | 1996-02-14 | Weston Medical Ltd | Needleless injector drug capsule and filling method |
| GB9602605D0 (en) | 1996-02-09 | 1996-04-10 | Weston Medical Ltd | Injection aid |
| JP3573431B2 (ja) | 1996-04-02 | 2004-10-06 | ウェストン メディカル リミテッド | 薬剤カプセルに充填する方法並びにそれによって製造される物品 |
| GB9607549D0 (en) | 1996-04-11 | 1996-06-12 | Weston Medical Ltd | Spring-powered dispensing device |
| NL1004059C2 (nl) | 1996-09-18 | 1998-03-19 | Plastic Moulding Appliances B | Samenstel van houder en breeksluiting en werkwijze voor de vervaardiging daarvan. |
| DE69713513T2 (de) | 1996-09-25 | 2002-10-31 | Weston Medical Ltd., Stradbroke Eye | Verfahren und vorrichtung zur herstellung von gegenständen aus verformbarem material |
| US6258059B1 (en) | 1997-02-06 | 2001-07-10 | Weston Medical Limited | Injection aid |
| US6179583B1 (en) | 1997-02-25 | 2001-01-30 | Weston Medical Limited | Metered fluid delivery device |
| GB9818110D0 (en) * | 1998-08-19 | 1998-10-14 | Weston Medical Ltd | Needleless injectors and other devices |
| US6319224B1 (en) * | 1999-08-20 | 2001-11-20 | Bioject Medical Technologies Inc. | Intradermal injection system for injecting DNA-based injectables into humans |
| US20050027239A1 (en) | 1999-08-20 | 2005-02-03 | Stout Richard R. | Intradermal injection system for injecting DNA-based injectables into humans |
| KR20030071780A (ko) | 2000-11-30 | 2003-09-06 | 바이오밸브 테크놀로지스, 인코포레이티드 | 주입기 |
| DE10129583A1 (de) | 2001-06-20 | 2003-01-09 | Disetronic Licensing Ag | Vorrichtung und Verfahren zu Injektion |
| GB0125506D0 (en) * | 2001-10-24 | 2001-12-12 | Weston Medical Ltd | Needle free injection method and apparatus |
| JP4234676B2 (ja) | 2002-07-11 | 2009-03-04 | テクファーマ・ライセンシング・アクチェンゲゼルシャフト | 皮内及び皮下注射装置 |
| EP1558306B1 (fr) * | 2002-07-11 | 2006-12-27 | Tecpharma Licensing AG | Dispositif d injection intradermique et sous cutanee |
| US20060258986A1 (en) * | 2005-02-11 | 2006-11-16 | Hunter Ian W | Controlled needle-free transport |
| US20070055199A1 (en) | 2005-08-10 | 2007-03-08 | Gilbert Scott J | Drug delivery device for buccal and aural applications and other areas of the body difficult to access |
| EP1976581A1 (en) | 2006-01-23 | 2008-10-08 | Yoshio Oyama | An ampoule usable as a syringe and a syringe unit comprising the ampoule |
| FR2903908B1 (fr) * | 2006-07-18 | 2009-02-27 | Crossject Sa | Dispositif d'injection sans aiguille a double stoppeur a profils de pression abaisses |
| CA2666755C (en) * | 2006-09-01 | 2014-03-25 | Massachusetts Institute Of Technology | Needle-free injector device with autoloading capability |
| CN201342161Y (zh) * | 2009-01-10 | 2009-11-11 | 陈凯 | 一种由激光驱动的微喷射装置 |
| CN201361320Y (zh) * | 2009-02-26 | 2009-12-16 | 陈凯 | 用于液体喷射注射的推射装置 |
| US8734384B2 (en) * | 2010-09-15 | 2014-05-27 | Zogenix, Inc. | Needle-free injectors and design parameters thereof that optimize injection performance |
-
2011
- 2011-09-14 US US13/232,820 patent/US8734384B2/en not_active Expired - Fee Related
- 2011-09-14 CN CN201510167794.5A patent/CN104958813A/zh active Pending
- 2011-09-14 WO PCT/US2011/051617 patent/WO2012037268A2/en not_active Ceased
- 2011-09-14 AU AU2011302072A patent/AU2011302072B2/en not_active Ceased
- 2011-09-14 JP JP2013529302A patent/JP5856621B2/ja not_active Expired - Fee Related
- 2011-09-14 EP EP11825883.9A patent/EP2616123A4/en not_active Withdrawn
- 2011-09-14 CN CN201180044022.2A patent/CN103153370B/zh not_active Expired - Fee Related
- 2011-09-14 CA CA2810078A patent/CA2810078A1/en not_active Abandoned
-
2014
- 2014-04-14 US US14/251,959 patent/US9265888B2/en not_active Expired - Fee Related
-
2015
- 2015-12-11 JP JP2015241941A patent/JP6113260B2/ja not_active Expired - Fee Related
-
2016
- 2016-01-15 US US14/996,977 patent/US9662449B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP2616123A4 (en) | 2014-11-26 |
| AU2011302072B2 (en) | 2014-05-15 |
| CN103153370A (zh) | 2013-06-12 |
| US20120065615A1 (en) | 2012-03-15 |
| JP5856621B2 (ja) | 2016-02-10 |
| WO2012037268A2 (en) | 2012-03-22 |
| US9265888B2 (en) | 2016-02-23 |
| WO2012037268A3 (en) | 2013-05-30 |
| JP2016052595A (ja) | 2016-04-14 |
| AU2011302072A1 (en) | 2013-03-28 |
| US20160129191A1 (en) | 2016-05-12 |
| US9662449B2 (en) | 2017-05-30 |
| CN103153370B (zh) | 2015-05-13 |
| CN104958813A (zh) | 2015-10-07 |
| JP2013540488A (ja) | 2013-11-07 |
| US8734384B2 (en) | 2014-05-27 |
| EP2616123A2 (en) | 2013-07-24 |
| JP6113260B2 (ja) | 2017-04-12 |
| US20140221915A1 (en) | 2014-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9662449B2 (en) | Needle-free injectors and design parameters thereof that optimize injection performance | |
| AU2012205735B2 (en) | Needle free injectors | |
| CN1225293C (zh) | 用于将液态药物皮内注射到人体的系统 | |
| US20140005632A1 (en) | Needle-Less Injector and Method of Fluid Delivery | |
| US20170065771A1 (en) | Piston closures for drug delivery capsules | |
| Vadlapatla et al. | Needle-free injectors | |
| AU2013203986B2 (en) | Improved Needle Free Injectors | |
| WO2016137665A1 (en) | Needle-free injectors comprising sound suppression | |
| Labu | Comparative Studies of Needle Free Injection Systems and Hypodermic Needle Injection: A Global Perspective | |
| Rahman et al. | Comparative Studies of N Needle I | |
| Rahman et al. | Comparative Studies of Needle Free Needle Injection: A |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20160815 |
|
| FZDE | Dead |
Effective date: 20190916 |